Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / DPP4

DPP4

Basics

Aliases:
This biomarker is also known as:
  • dipeptidyl peptidase IV,
  • ADCP-2,
  • DPP IV,
  • Dipeptidyl peptidase IV,
  • CD26 antigen,
  • ADABP,
  • dipeptidyl-peptidase 4,
  • CD26,
  • T-cell activation antigen CD26,
  • dipeptidyl peptidase 4,
  • EC 3.4.14.5,
  • adenosine deaminase complexing protein 2,
  • dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2),
  • DPPIV,
  • ADCP2,
  • dipeptidylpeptidase 4,
  • Adenosine deaminase complexing protein 2,
  • TP103,

View in BioMuta

Description…

dipeptidyl-peptidase 4

Attributes

QA State: Curated
Type: Gene
Short Name:
HGNC Name: DPP4

Datasets

There are no datasets associated with this biomarker.

Organs

The following organs have data associated with this biomarker…

Prostate

Attributes

Phase: One
QA State: Under Review

Overview

No additional prostate data available.

Performance Comment

19 common probe sets (15 unique genes) were used to develop a PAM-based classifier, which had an average accuracy of 87% when it was tested on 47 independent tumor-adjacent stroma samples. The 15 genes represented in the classifier are: GADD45B, CDKN1A, NLRP1, ERBB3, FMO5, KIAA0746///SERINC2, AMFR, DPP4, PGC, YWHAE, EHF, TF, TNFSF10, EIF5A, TGM4. This is the first general tumor microenvironment-based prognostic classifier. Tumor-adjacent prostate cancer stroma contains numerous changes in gene expression at the time of diagnosis that correlate with the chance of relapse following prostatectomy. These results indicate that the prostate cancer microenvironment exhibits reproducible changes useful for predicting outcomes for patients.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.

Announcement